Insider Selling: MedEquities Realty Trust Inc (MRT) Director Sells 10,000 Shares of Stock

MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 10,000 shares of the stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $8.45, for a total transaction of $84,500.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Monday, October 29th, Bluemountain Capital Managemen sold 11,695 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.39, for a total transaction of $98,121.05.
  • On Thursday, October 25th, Bluemountain Capital Managemen sold 25,546 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.45, for a total transaction of $215,863.70.
  • On Monday, October 22nd, Bluemountain Capital Managemen sold 5,463 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.65, for a total transaction of $47,254.95.
  • On Friday, October 19th, Bluemountain Capital Managemen sold 5,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.54, for a total transaction of $42,700.00.
  • On Wednesday, October 17th, Bluemountain Capital Managemen sold 23,200 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.84, for a total transaction of $205,088.00.
  • On Friday, October 12th, Bluemountain Capital Managemen sold 10,000 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.74, for a total transaction of $87,400.00.
  • On Monday, October 15th, Bluemountain Capital Managemen sold 21,289 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $8.80, for a total transaction of $187,343.20.
  • On Wednesday, October 10th, Bluemountain Capital Managemen sold 12,816 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $9.16, for a total transaction of $117,394.56.
  • On Friday, October 5th, Bluemountain Capital Managemen sold 3,955 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $9.13, for a total transaction of $36,109.15.
  • On Monday, October 8th, Bluemountain Capital Managemen sold 18,052 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $9.20, for a total transaction of $166,078.40.

MRT opened at $8.52 on Friday. The firm has a market cap of $271.47 million, a P/E ratio of 7.10 and a beta of 0.65. MedEquities Realty Trust Inc has a twelve month low of $8.25 and a twelve month high of $12.04.

MedEquities Realty Trust (NYSE:MRT) last released its quarterly earnings results on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.30 by ($0.20). The firm had revenue of $17.56 million for the quarter, compared to analyst estimates of $17.03 million. MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. Equities analysts anticipate that MedEquities Realty Trust Inc will post 1.08 earnings per share for the current year.

A number of equities research analysts recently weighed in on the stock. JMP Securities set a $12.00 price target on shares of MedEquities Realty Trust and gave the company a “buy” rating in a report on Tuesday, October 23rd. Zacks Investment Research raised shares of MedEquities Realty Trust from a “strong sell” rating to a “hold” rating in a report on Wednesday, October 10th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $10.00 price target (down from $12.00) on shares of MedEquities Realty Trust in a report on Friday, September 28th. ValuEngine lowered shares of MedEquities Realty Trust from a “sell” rating to a “strong sell” rating in a report on Friday, September 14th. Finally, Citigroup lowered shares of MedEquities Realty Trust from a “neutral” rating to a “sell” rating and lowered their price target for the company from $10.00 to $9.00 in a report on Friday, September 14th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $11.25.

A number of hedge funds have recently made changes to their positions in MRT. Renaissance Technologies LLC grew its holdings in MedEquities Realty Trust by 36.0% during the 2nd quarter. Renaissance Technologies LLC now owns 839,800 shares of the financial services provider’s stock worth $9,255,000 after acquiring an additional 222,500 shares in the last quarter. American Century Companies Inc. grew its holdings in MedEquities Realty Trust by 7.1% during the 3rd quarter. American Century Companies Inc. now owns 2,325,880 shares of the financial services provider’s stock worth $22,608,000 after acquiring an additional 153,969 shares in the last quarter. Sterling Capital Management LLC acquired a new position in MedEquities Realty Trust during the 2nd quarter worth $957,000. BlackRock Inc. grew its holdings in MedEquities Realty Trust by 5.5% during the 2nd quarter. BlackRock Inc. now owns 1,499,494 shares of the financial services provider’s stock worth $16,526,000 after acquiring an additional 77,884 shares in the last quarter. Finally, First Trust Advisors LP acquired a new position in MedEquities Realty Trust during the 3rd quarter worth $516,000. 90.87% of the stock is owned by institutional investors.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Recommended Story: How can you know how many shares are floating?

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply